Creative Planning’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1K | Hold |
21,295
| – | – | ﹤0.01% | 4066 |
|
|
2025
Q4 | $13.6K | Sell |
21,295
-160
| -0.7% | -$123 | ﹤0.01% | 3861 |
|
|
2025
Q3 | $20K | Sell |
21,455
-660
| -3% | -$650 | ﹤0.01% | 3820 |
|
|
2025
Q2 | $28.3K | Sell |
22,115
-1,000
| -4% | -$1K | ﹤0.01% | 3573 |
|
|
2025
Q1 | $23.1K | Buy |
23,115
+1,820
| +9% | +$1.92K | ﹤0.01% | 3396 |
|
|
2024
Q4 | $19.4K | Hold |
21,295
| – | – | ﹤0.01% | 3343 |
|
|
2024
Q3 | $31.9K | Hold |
21,295
| – | – | ﹤0.01% | 3125 |
|
|
2024
Q2 | $15K | Hold |
21,295
| – | – | ﹤0.01% | 3001 |
|
|
2024
Q1 | $20.2K | Hold |
21,295
| – | – | ﹤0.01% | 2835 |
|
|
2023
Q4 | $23.6K | Hold |
21,295
| – | – | ﹤0.01% | 2688 |
|
|
2023
Q3 | $40K | Hold |
21,295
| – | – | ﹤0.01% | 2509 |
|
|
2023
Q2 | $76.4K | Hold |
21,295
| – | – | ﹤0.01% | 2391 |
|
|
2023
Q1 | $71.8K | Hold |
21,295
| – | – | ﹤0.01% | 2297 |
|
|
2022
Q4 | $33K | Hold |
21,295
| – | – | ﹤0.01% | 2278 |
|
|
2022
Q3 | $29K | Sell |
21,295
-2,120
| -9% | -$4.14K | ﹤0.01% | 2161 |
|
|
2022
Q2 | $51K | Buy |
23,415
+2,120
| +10% | +$4.87K | ﹤0.01% | 2051 |
|
|
2022
Q1 | $68K | Sell |
21,295
-1,000
| -4% | -$3.58K | ﹤0.01% | 2027 |
|
|
2021
Q4 | $93K | Buy |
22,295
+200
| +0.9% | +$1.12K | ﹤0.01% | 1960 |
|
|
2021
Q3 | $179K | Buy |
22,095
+300
| +1% | +$2.44K | ﹤0.01% | 1879 |
|
|
2021
Q2 | $165K | Sell |
21,795
-4,800
| -18% | -$40.4K | ﹤0.01% | 1825 |
|
|
2021
Q1 | $231K | Hold |
26,595
| – | – | ﹤0.01% | 1982 |
|
|
2020
Q4 | $212K | Buy |
26,595
+200
| +0.8% | +$1.67K | ﹤0.01% | 1858 |
|
|
2020
Q3 | $211K | Sell |
26,395
-8,340
| -24% | -$75.2K | ﹤0.01% | 1651 |
|
|
2020
Q2 | $344K | Buy |
34,735
+2,773
| +9% | +$25.5K | ﹤0.01% | 1232 |
|
|
2020
Q1 | $247K | Sell |
31,962
-2,278
| -7% | -$11.5K | ﹤0.01% | 1269 |
|
|
2019
Q4 | $132K | Sell |
34,240
-150
| -0.4% | -$654 | ﹤0.01% | 1719 |
|
|
2019
Q3 | $173K | Hold |
34,390
| – | – | ﹤0.01% | 1638 |
|
|
2019
Q2 | $227K | Hold |
34,390
| – | – | ﹤0.01% | 1535 |
|
|
2019
Q1 | $260K | Buy |
34,390
+300
| +0.9% | +$2.34K | ﹤0.01% | 1415 |
|
|
2018
Q4 | $275K | Hold |
34,090
| – | – | ﹤0.01% | 1287 |
|
|
2018
Q3 | $440K | Sell |
34,090
-20,000
| -37% | -$251K | ﹤0.01% | 1158 |
|
|
2018
Q2 | $617K | Buy |
+54,090
| New | +$512K | ﹤0.01% | 961 |
|
|
2017
Q3 | – | Sell |
-6,200
| Closed | -$27K | – | 2268 |
|
|
2017
Q2 | $27K | Buy |
6,200
+300
| +5% | +$1.31K | ﹤0.01% | 2953 |
|
|
2017
Q1 | $27K | Buy |
5,900
+400
| +7% | +$2.23K | ﹤0.01% | 2906 |
|
|
2016
Q4 | $30K | Hold |
5,500
| – | – | ﹤0.01% | 2783 |
|
|
2016
Q3 | $35K | Hold |
5,500
| – | – | ﹤0.01% | 2633 |
|
|
2016
Q2 | $25K | Hold |
5,500
| – | – | ﹤0.01% | 2634 |
|
|
2016
Q1 | $22K | Buy |
5,500
+5,000
| +1,000% | +$21.7K | ﹤0.01% | 2687 |
|
|
2015
Q4 | $3K | Buy |
+500
| New | +$3.4K | ﹤0.01% | 3894 |
|
Other funds holding CTSO
AC
VCM
SC
CM
SIG
VFT
Creative Planning's CTSO Position: Q1 2026 in Review
Creative Planning held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 21,295 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.
Creative Planning first reported a position in CTSO in Q4 2015 and has held it in 39 quarters since. The position peaked at $617K in Q2 2018. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.
- Creative Planning held 21,295 shares of Cytosorbents Corp worth $12.1K as of Q1 2026.
- Creative Planning left its Cytosorbents Corp share count unchanged in Q1 2026.
- Cytosorbents Corp made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4066 holding.
- Creative Planning first reported a position in Cytosorbents Corp in Q4 2015 and has held it in 39 quarters since.
- Creative Planning's Cytosorbents Corp position peaked at $617K in Q2 2018.
- 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.